PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
Clinical trial NCT06069830 · RECRUITING
Trial details
- NCT number
- NCT06069830
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2026-10-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.